Search Results - "Pouptsis, Athanasios"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Surgical and Systemic Treatment of Hereditary Breast Cancer: A Mini-Review With a Focus on BRCA1 and BRCA2 Mutations by Pouptsis, Athanasios, Swafe, Leyla, Patwardhan, Maneesha, Stavraka, Chara

    Published in Frontiers in oncology (20-10-2020)
    “…Hereditary breast cancer accounts for 5%-10% of breast cancer cases. The majority of familial cases have been linked to germline mutations in BRCA1 and BRCA2…”
    Get full text
    Journal Article
  2. 2

    Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options by Personeni, Nicola, Lleo, Ana, Pressiani, Tiziana, Colapietro, Francesca, Openshaw, Mark Robert, Stavraka, Chara, Pouptsis, Athanasios, Pinato, David James, Rimassa, Lorenza

    Published in Cancers (13-11-2020)
    “…Most patients with biliary tract cancer (BTC) are diagnosed with advanced disease, relapse rates are high in those undergoing surgery and prognosis remains…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Metastatic Occult Primary Lobular Breast Cancer: A Case Report by Pouptsis, Athanasios, Cano Gimeno, Julia, Martinez Rubio, Carmen, Bañuls Marrades, Marta, Olivan Sasot, Patricia

    Published in Curēus (Palo Alto, CA) (19-04-2024)
    “…Breast cancer is the most common malignancy diagnosed in women. Invasive lobular breast cancer (ILC) is the second most common histologic subtype after…”
    Get full text
    Journal Article
  5. 5

    Clinical implementation of pre-treatment DPYD genotyping in capecitabine-treated metastatic breast cancer patients by Stavraka, Chara, Pouptsis, Athanasios, Okonta, Leroy, DeSouza, Karen, Charlton, Philip, Kapiris, Matthaios, Marinaki, Anthony, Karapanagiotou, Eleni, Papadatos-Pastos, Dionysis, Mansi, Janine

    Published in Breast cancer research and treatment (01-06-2019)
    “…Purpose Metastatic breast cancer (mBC) patients with DPYD genetic variants linked to loss of dihydropyrimidine dehydrogenase (DPD) activity are at risk of…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Primary resistance in docetaxel and androgen deprivation therapy in metastatic castrate sensitive prostate cancer patients by Pouptsis, Athanasios, Germanou, Styliani, Waldron, Nick, Young, Thomas, Khan, Madeha, Hughes, Simon, Josephs, Debra Hannah, Rudman, Sarah Maria, Enting, Deborah, Chowdhury, Simon

    Published in Journal of clinical oncology (20-02-2018)
    “…Abstract only 342 Background: Docetaxel chemotherapy combined with androgen deprivation therapy (ADT) has become the new standard of care in patients with…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    The potential benefit of trastuzumab-based therapy upon lapatinib progression in heavily preatreated patients with advanced HER2 positive breast cancer by Boutis, Anastasios L., Chatzileontiadou, Sofia, Diamantopoulos, Nikolaos, Pouptsis, Athanasios, Fotiou, Chariklia

    Published in Journal of clinical oncology (20-05-2013)
    “…Abstract only e11576 Background: Overexpression of human epidermal growth factor receptor 2 (HER2) occurring in about 20% of breast cancers is associated with…”
    Get full text
    Journal Article
  13. 13

    Metastatic Occult Primary Lobular Breast Cancer: A Case Report by Pouptsis, Athanasios, Cano Gimeno, Julia, Martinez Rubio, Carmen, Bañuls Marrades, Marta, Olivan Sasot, Patricia

    Published in Cureus (01-04-2024)
    “…Breast cancer is the most common malignancy diagnosed in women. Invasive lobular breast cancer (ILC) is the second most common histologic subtype after…”
    Get full text
    Report